Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis

被引:7
作者
YunJuan Nie [1 ]
ShuoHua Wu [2 ]
YingHua Xuan [3 ]
Gen Yan [4 ]
机构
[1] Department of Basic Medicine,Wuxi School of Medicine,Jiangnan University
[2] Department of Radiology,the Second Affiliated Hospital,Medical College of Shantou University
[3] Department of Basic Medicine,Xiamen Medical College
[4] Department of Radiology,the Second Affiliated Hospital of Xiamen Medical College
关键词
D O I
暂无
中图分类号
R563 [肺疾病];
学科分类号
1002 ; 100201 ;
摘要
Idiopathic pulmonary fibrosis(IPF) is a fatal chronic interstitial lung disease with no established treatment and is characterized by progressive scarring of the lung tissue and an irreversible decline in lung function. Chronic inflammation has been demonstrated to be the pathological basis of fibrosis. Emerging studies have revealed that most interleukin-17(IL-17) isoforms are essential for the mediation of acute and chronic inflammation via innate and adaptive immunity. Overexpression or aberrant expression of IL-17 cytokines contributes to various pathological outcomes, including the initiation and exacerbation of IPF. Here, we aim to provide an overview of IL-17 family members in the pathogenesis of IPF.
引用
收藏
页码:618 / 627
页数:10
相关论文
共 82 条
[1]  
Coagulation Factor-XII induces interleukin-6 by primary lung fibroblasts: A role in idiopathic pulmonary fibrosis?.[J].Jaffar Jade;McMillan Laura;Wilson Nick;Panousis Con;Hardy Charles;Cho Hyun Jung;Symons Karen;Glaspole Ian;Westall Glen;Wong Mae.American journal of physiology. Lung cellular and molecular physiology.2021, 2
[2]   Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease [J].
Kono, Masato ;
Miyashita, Koichi ;
Hirama, Ryutaro ;
Oshima, Yuiko ;
Takeda, Kenichiro ;
Mochizuka, Yasutaka ;
Tsutsumi, Akari ;
Miwa, Hideki ;
Miki, Yoshihiro ;
Hashimoto, Dai ;
Suda, Takafumi ;
Nakamura, Hidenori .
RESPIRATORY MEDICINE, 2021, 186
[3]   Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms [J].
Montero, Paula ;
Milara, Javier ;
Roger, Ines ;
Cortijo, Julio .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
[4]   IL-17C contributes to NTHi-induced inflammation and lung damage in experimental COPD and is present in sputum during acute exacerbations [J].
Vella, Giovanna ;
Ritzmann, Felix ;
Wolf, Lisa ;
Kamyschnikov, Andreas ;
Stodden, Hannah ;
Herr, Christian ;
Slevogt, Hortense ;
Bals, Robert ;
Beisswenger, Christoph .
PLOS ONE, 2021, 16 (01)
[5]  
Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis; Tissue Integrity; and Stromal Inflammation.[J].Stuart A. Cook;Sebastian Schafer.Annual Review of Medicine.2020, 1
[6]   Interleukin-17A: A Potential Therapeutic Target in Chronic Lung Diseases [J].
Shaikh, Sadiya Bi ;
Prabhu, Ashwini ;
Bhandary, Yashodhar Prabhakar .
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2019, 19 (07) :921-928
[7]   Acute Lung Injury: IL-17A-Mediated Inflammatory Pathway and Its Regulation by Curcumin [J].
Gouda, Mahesh Manjunath ;
Bhandary, Yashodhar Prabhakar .
INFLAMMATION, 2019, 42 (04) :1160-1169
[8]   Feature Article: IL-25 contributes to lung fibrosis by directly acting on alveolar epithelial cells and fibroblasts [J].
Xu, Xuefeng ;
Luo, Sa ;
Li, Biyun ;
Dai, Huaping ;
Zhang, Jinglan .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2019, 244 (09) :770-780
[9]   Interleukin-17: Potential Target for Chronic Wounds [J].
Hadian, Yasmin ;
Bagood, Michelle D. ;
Dahle, Sara E. ;
Sood, Apra ;
Isseroff, R. Roslyn .
MEDIATORS OF INFLAMMATION, 2019, 2019
[10]   IL-1β, IL-23, and TGF-β drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation [J].
Golebski, Korneliusz ;
Ros, Xavier R. ;
Nagasawa, Maho ;
van Tol, Sophie ;
Heesters, Balthasar A. ;
Aglmous, Hajar ;
Kradolfer, Chantal M. A. ;
Shikhagaie, Medya M. ;
Seys, Sven ;
Hellings, P. W. ;
van Drunen, Cornelis M. ;
Fokkens, Wytske J. ;
Spits, Hergen ;
Bal, Suzanne M. .
NATURE COMMUNICATIONS, 2019, 10 (1)